Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -123,478 | -84,707 | -40,438 | -196,767 | -155,738 |
| Depreciation Amortization | 21,617 | 14,409 | 7,125 | 23,438 | 17,314 |
| Accounts receivable | -1,156 | -2,615 | -613 | 1,574 | 2,258 |
| Accounts payable and accrued liabilities | -2,802 | -4,491 | -4,565 | -2,151 | -6,965 |
| Other Working Capital | -22,724 | -8,450 | -21,619 | 70,176 | 65,055 |
| Other Operating Activity | 10,025 | 11,011 | 8,238 | -63,893 | -60,846 |
| Operating Cash Flow | $-118,518 | $-74,843 | $-51,872 | $-167,623 | $-138,922 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,691 | -6,860 | -2,876 | -17,351 | -14,074 |
| Purchase Of Investment | -132,229 | -97,343 | -58,467 | -554,239 | -422,237 |
| Sale Of Investment | 232,812 | 181,953 | 76,490 | 593,998 | 430,653 |
| Other Investing Activity | -22,355 | -26,355 | -8,509 | 97,177 | 92,959 |
| Investing Cash Flow | $69,537 | $51,395 | $6,638 | $119,585 | $87,301 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 27,460 | 13,460 |
| Debt Repayment | -12,563 | -12,563 | -77 | -1,951 | -1,621 |
| Common Stock Issued | 5,181 | 4,474 | 2,913 | 11,959 | 8,949 |
| Other Financing Activity | -4,722 | -2,921 | -2,897 | 0 | 0 |
| Financing Cash Flow | $-12,104 | $-11,010 | $-61 | $37,468 | $20,788 |
| Exchange Rate Effect | -37 | -9 | 143 | 631 | 184 |
| Beginning Cash Position | 98,159 | 98,159 | 98,159 | 108,098 | 108,098 |
| End Cash Position | 37,037 | 63,692 | 53,007 | 98,159 | 77,449 |
| Net Cash Flow | $-61,122 | $-34,467 | $-45,152 | $-9,939 | $-30,649 |
| Free Cash Flow | |||||
| Operating Cash Flow | -118,518 | -74,843 | -51,872 | -167,623 | -138,922 |
| Capital Expenditure | -8,691 | -6,860 | -2,876 | -17,351 | -13,230 |
| Free Cash Flow | -127,209 | -81,703 | -54,748 | -184,974 | -152,152 |